Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interest In Transradial PCI Grows In U.S. But Barriers Remain

This article was originally published in The Gray Sheet

Executive Summary

The standing-room-only crowd of physicians that packed a meeting room at the recent Transcatheter Cardiovascular Therapeutics conference in San Francisco to hear presentations on transradial percutaneous coronary interventions suggests interest in the technique is growing in the U.S

You may also be interested in...



Big Data In The Big Easy: Sapien Versus Surgery Results Get Top ACC Billing

Transcatheter aortic heart valve data, and Edwards Lifesciences' Sapien valve in particular, are set to take the spotlight at yet another major cardiology conference this weekend.

Big Data In The Big Easy: Sapien Versus Surgery Results Get Top ACC Billing

Transcatheter aortic heart valve data, and Edwards Lifesciences' Sapien valve in particular, are set to take the spotlight at yet another major cardiology conference this weekend.

Radial Approach to Angioplasty Gaining Momentum

If technology changes and clinical outcomes assert their influence over standard protocols, an increasing number of Americans patients will undergo coronary angioplasty through the radial artery in their wrist, not the femoral artery in their groin. As studies are beginning to portray more clearly, those patients are likely to be more comfortable postprocedure, exhibit less bleeding, and recover more quickly than patients treated treated with the traditional femoral approach.

Topics

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel